                         SEQUENCE LISTING

<110>  ADVANCED ACCELERATOR APPLICATIONS S.A.
 
<120>  Compounds modulators of VEGF activity and uses thereof

<130>  10541PTWO

<150>  US provisional 61/228/384
<151>  2009-07-24

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  prepared by chemical synthesis


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  linear

<400>  1

Lys Gln Ile Met Trp Ile Lys Pro His Gln Gly Gln Trp Ile Tyr Thr 
1               5                   10                  15      


Ser 
    


<210>  2
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  prepared by chemical synthesis


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  cyclic: Cys residues make a disulfide bond

<220>
<221>  DISULFID
<222>  (3)..(15)

<400>  2

Lys Gln Cys Met Trp Ile Lys Pro His Gln Gly Gln Trp Thr Cys Thr 
1               5                   10                  15      


Ser 
    


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  prepared by chemical synthesis


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  linear

<400>  3

Lys Gln Leu Leu Trp Ile Arg Ser Gly Asp Arg Pro Trp Tyr Tyr Thr 
1               5                   10                  15      


Ser 
    


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  prepared by chemical synthesis


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  cyclic: Cys residues make a disulfide bond

<220>
<221>  DISULFID
<222>  (3)..(15)

<400>  4

Lys Gln Cys Leu Trp Ile Arg Ser Gly Asp Arg Pro Trp Tyr Cys Thr 
1               5                   10                  15      


Ser 
    


<210>  5
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PREPARED BY CHEMICAL SYNTHESIS


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  linear or cyclic

<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Met or Leu or their homolog or ortolog

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  Pro or Ser or their homolog or ortolog

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  His or Gly or their homolog or ortolog

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  Gln or Pro or their homolog or ortolog

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  any natural or unnatural amino acid

<220>
<221>  VARIANT
<222>  (14)..(14)
<223>  Ile or Tyr or their homolog or ortolog

<220>
<221>  VARIANT
<222>  (15)..(17)
<223>  any natural or unnatural amino acid

<400>  5

Xaa Gln Xaa Xaa Xaa Ile Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  6
<211>  14
<212>  PRT
<213>  Homo sapiens


<220>
<221>  PEPTIDE
<222>  (1)..(14)
<223>  VEGF (UniProtKB/Swiss-Prot P15692) amino acid sequence 79-92

<300>
<308>  UniProtKB Swiss-Prot / P15692
<309>  1990-04-01
<313>  (79)..(92)

<400>  6

Gln Ile Met Arg Ile Lys Pro His Gln Gly Gln His Ile Gly 
1               5                   10                  


<210>  7
<211>  14
<212>  PRT
<213>  Homo sapiens


<220>
<221>  PEPTIDE
<222>  (1)..(14)
<223>  PlGF (UniProtKB/Swiss-Prot P49763) sequence 87-100

<300>
<308>  UniProtKB/Swiss-Prot P49763
<309>  1996-10-01
<313>  (87)..(100)

<400>  7

Gln Leu Leu Lys Ile Arg Ser Gly Asp Arg Pro Ser Tyr Val 
1               5                   10                  


